Trial of Vitamin C as Add on Therapy for Children With Idiopathic Epilepsy
This trial is active, not recruiting.
|Sponsor||Ain Shams University|
|Start date||February 2015|
|End date||September 2015|
|Trial size||60 participants|
|Trial identifier||NCT02369822, Vitamin C, Children, Epilepsy|
There are no solid treatment guidelines for idiopathic intractable epilepsy in children. The investigators propose that vitamin C being an antioxidant will improve seizure frequency and EEG in children with idiopathic intractable epilepsy.
|Endpoint classification||safety/efficacy study|
|Intervention model||factorial assignment|
Seizure severity and frequency, EEG findings
time frame: up to 30 days
vitamin C level in children with epilepsy
time frame: 6 months
Male or female participants from 2 years up to 16 years old.
Inclusion Criteria: - Normal neuroimaging Exclusion Criteria: - Developmental delay. - Suspected metabolic problems.
|Official title||Trial of Vitamin C as Add on Therapy for Children With Idiopathic Epilepsy|
|Description||Is vitamin C; being an antioxidant based on the hypothesis of oxidative stress as a provocation factor for idiopathic epilepsy low in those with idiopathic epilepsy, and is it lower in those with refractory than those with newly diagnosed? Will vitamin C supplementation for 1 month be efficient to raise the vitamin C level and will it improve seizures and EEG findings in those with idiopathic epilepsy?|
Call for more information